Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stage (marketwatch.com)
This is the first time that investigational COVID-19 vaccines have been reported to have a T-cell response
Britain's Prince William, Duke of Cambridge (2L), wearing PPE (personal protective equipment), of a face mask or covering, eye protection and an overall as a precautionary measure against spreading COVID-19, meets scientists including Christina Dold (R) during a visit to the manufacturing laboratory where a vaccine against the novel coronavirus COVID-19 has been produced at the Oxford Vaccine Group's facility at the Churchill Hospital in Oxford, west of London on June 24, 2020, during a visit to learn more about their work to establish a viable vaccine against coronavirus. (Photo by Steve Parsons / POOL / AFP) (Photo by STEVE PARSONS/POOL/AFP via Getty Images) Getty Images
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a more durable form of immunity than an antibody response.
- Log in to post comments
